Conversion from sandimmune to neoral at two different dose-ratio in stable renal transplant patients.

被引:0
|
作者
Gaspari, F
Perico, N
Pisoni, R
Anedda, MF
Signorini, O
Gotti, E
Remuzzi, G
机构
[1] MARIO NEGRI INST PHARMACOL RES, I-24100 BERGAMO, ITALY
[2] OSPED RIUNITI BERGAMO, BERGAMO, ITALY
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A3314 / A3314
页数:1
相关论文
共 50 条
  • [31] ECONOMIC-ANALYSIS OF SANDIMMUNE-NEORAL IN CANADA IN STABLE RENAL-TRANSPLANT PATIENTS
    KEOWN, P
    LAWEN, JG
    LANDSBERG, D
    BEAUREGARDZOLLINGER, L
    RIVIERE, M
    LECLERC, C
    HARDENS, M
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (02) : 1845 - 1848
  • [32] An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients
    Park, K
    Koh, YB
    Kwak, JY
    Kim, SJ
    Yoon, YS
    Kang, CM
    Kim, YS
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1202 - 1203
  • [33] An assessment of outcomes associated with conversion to neoral in cadaveric renal transplant patients.
    Pelletier, R
    Grauer, D
    Zagari, M
    Nunez, S
    DiCesare, J
    Ferguson, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3245 - A3245
  • [34] Neoral conversion in stable thoracic transplant patients leads to dose reduction
    Zaldonis, DB
    Keenan, RJ
    Pham, SM
    Kormos, RL
    Griffith, BP
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1898 - 1899
  • [35] Neoral conversion in stable thoracic transplant patients leads to dose reduction
    Zaldonis, DB
    Keenan, RJ
    Pham, SM
    Kormos, RL
    Griffith, BP
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1158 - 1159
  • [36] Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method
    First, MR
    Weiskittel, P
    Shah, M
    Peddi, VR
    Canafax, D
    Schroeder, TJ
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 3955 - 3957
  • [37] Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from Sandimmune to Neoral in stable renal transplant patients
    Yoshida, K
    Kimura, T
    Hamada, Y
    Saito, T
    Endo, T
    Baba, S
    Shimada, S
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3146 - 3147
  • [38] Conversion to Neoral in stable renal transplant recipients.
    Pescovitz, MD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3360 - A3360
  • [39] Conversion from Sandimmun to Neoral in stable pediatric renal transplant recipients
    Hoyer, PF
    Bökenkamp, A
    PEDIATRIC NEPHROLOGY, 1998, 12 (03) : 260 - 261
  • [40] CONVERSION TO NEORAL IN STABLE RENAL-TRANSPLANT RECIPIENTS
    PESCOVITZ, MD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1111 - 1111